Scientists have discovered a critical part of the body’s immune system with potentially major implications for the treatment of some of the most devastating diseases affecting humans.
Professor Graham Lord, from The University of Manchester, led the study, which could translate into treatments for autoimmune diseases including Cancer, Diabetes, Multiple Sclerosis and Crohn’s Disease within a few years.
It is published in The Journal of Clinical Investigation today.
The discovery of the molecular pathway regulated by a tiny molecule – known as microRNA-142 – is a major advance in our understanding of the immune system.
The 10-year-study found that microRNA-142 controls Regulatory T cells, which modulate the immune system and prevent autoimmune disease. It is, they found, the most highly expressed regulator in the immune system.
Autoimmune diseases often target people in the prime of their life creating a significant socio-economic burden on them. Sometimes, the effect can be devastating, causing terrible hardship and suffering. But these findings represent a significant step forward in the understanding of the immune system and we believe many people worldwide may benefit
Professor Graham Lord
And according to Professor Lord, the discovery could be translated into a viable drug treatment within a few years.
He said: “Autoimmune diseases often target people in the prime of their life creating a significant socio-economic burden on them. Sometimes, the effect can be devastating, causing terrible hardship and suffering.
“But these findings represent a significant step forward in the understanding of the immune system and we believe many people worldwide may benefit.”
If the activity of Regulatory T cells is too low, this can cause other immune cells to attack our own body tissues. If these Regulatory T cells are too active, this leads to suppression of immune responses and can allow cancers to evade the immune system.
So being able to control them is a major step forward in our ability to control- and harness – the therapeutic power of the immune system.
Professor Richard Jenner from UCL, who led the computational side of the project, said that: “We were able to trace the molecular fingerprints of this molecule across other genes to determine how it acted as such a critical regulator.”
Professor Lord, now Vice President and Dean of the Faculty of Biology, Medicine and Health at The University of Manchester, added: “Scientists over the past decade or so have developed therapies which are able to modulate different pathways of the immune system. We hope that this new discovery will lead to the development of new ways to treat autoimmunity, infectious diseases and cancer and we are incredibly excited about where this may lead.”
The Latest on: Autoimmune diseases
via Google News
The Latest on: Autoimmune diseases
- Gluten May Cause Celiac Disease in Childrenon August 16, 2019 at 11:39 am
A new study shows that children who are predisposed to celiac disease can get the autoimmune disorder in the first five years of their life if they consume gluten. Veuer's Taisha Henry has the story.
- IgA Nephropathy Patients Invited to Speak About their Disease to the FDAon August 16, 2019 at 10:05 am
IgAN (Immunoglobulin A nephropathy), formerly known as Berger's disease, damages the glomeruli (filters) inside the kidneys. The causes of IgAN are not well understood. IgAN is an autoimmune ...
- Beyond Celiac Awards Nearly $450,000 in Research Grants for Groundbreaking Studies on Celiac Diseaseon August 16, 2019 at 5:51 am
“The scientific world is looking at celiac disease as part of the broader autoimmune disease spectrum, and progress is being made as a result. At Beyond Celiac, we remain committed to our ...
- Brandy Zwicker, RN Wants Women to Know Their Risk Factors & Warning Signs of Heart Disorderson August 15, 2019 at 5:02 pm
Brandy Zwicker explained, “With so much focus on other diseases that affect women, like breast cancer and autoimmune disorders, heart disease is often overlooked and underestimated. One woman ...
- Pediatric hepatology: 6 reports on treating liver disease in childrenon August 15, 2019 at 11:19 am
Liver disease in children and adolescents takes on as many forms as in adults, including viral hepatitis, autoimmune diseases, fatty liver disease, and even the pediatric-specific biliary atresia that ...
- Warm Autoimmune Hemolytic Anemiaon August 14, 2019 at 2:18 pm
Robert A. Brodsky, M.D. Warm autoimmune hemolytic anemia is a chronic, relapsing disease characterized by anemia, reticulocytosis, other evidence of hemolysis, and a positive direct antiglobulin test.
- Autoimmune Disease Diagnostics Market is Heading Up 16 Billion US$ By 2026on August 13, 2019 at 4:29 am
The global Autoimmune Disease Diagnostics Market is anticipated to around US$ 16 Billion by 2026. The market is anticipated to grow at a CAGR of 2.8% from 2018 to 2026. Autoimmune Disease Diagnostics ...
- Strategic in-licensing Related to Autoimmune Hepatitis in the US Marketon August 12, 2019 at 6:19 am
Autoimmune hepatitis (AIH), formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be ...
- World Autoimmune Disease Diagnosis Market Forecast, 2019-2025 - ResearchAndMarkets.comon August 9, 2019 at 9:00 am
The "Autoimmune Disease Diagnosis - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering. Autoimmune Disease Diagnosis market worldwide is projected to ...
- The Global Market for Autoimmune Disease Diagnosis (2019-2025): Consumables & Assay Kits Segment Poised to Exceed $3.1 Billion by 2025on August 9, 2019 at 6:44 am
Dublin, Aug. 09, 2019 (GLOBE NEWSWIRE) -- The "Autoimmune Disease Diagnosis - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering. Autoimmune Disease ...
via Bing News